NewEdge Wealth LLC Makes New Investment in Cigna Group $CI

NewEdge Wealth LLC purchased a new position in shares of Cigna Group (NYSE:CI) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 5,291 shares of the health services provider’s stock, valued at approximately $1,459,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Wilkerson Advisory Group LLC purchased a new position in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Kemnay Advisory Services Inc. purchased a new stake in Cigna Group during the 4th quarter worth approximately $29,000. Prosperity Bancshares Inc purchased a new stake in Cigna Group during the 4th quarter worth approximately $29,000. Cedar Mountain Advisors LLC lifted its holdings in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after buying an additional 68 shares in the last quarter. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in Cigna Group during the 2nd quarter worth approximately $34,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 over the last ninety days. 0.60% of the stock is owned by company insiders.

Cigna Group Trading Up 0.6%

Shares of NYSE:CI opened at $276.19 on Friday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company’s 50 day moving average is $284.20 and its two-hundred day moving average is $281.38. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a market cap of $72.98 billion, a PE ratio of 11.43, a P/E/G ratio of 0.94 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the business earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is 25.82%.

Analysts Set New Price Targets

Several research firms have commented on CI. Royal Bank Of Canada boosted their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Morgan Stanley increased their price objective on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Wolfe Research reiterated an “outperform” rating and issued a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. The Goldman Sachs Group boosted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Cantor Fitzgerald increased their price target on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.